Wilzin is a medication primarily used in the treatment of Wilson's disease, a rare genetic disorder characterized by the body's inability to properly eliminate copper, leading to its accumulation in organs such as the liver and brain. The active ingredient in Wilzin is zinc acetate, which works by blocking the absorption of copper from the stomach and promoting its excretion from the body. This helps in reducing the levels of copper and preventing the damage it can cause to various organs. Wilzin is available in capsule form and is usually taken orally, with the dosage and treatment regimen tailored to the individual patient's needs and copper levels. It is important for patients taking Wilzin to follow their healthcare provider's instructions closely and to undergo regular monitoring of their copper levels to ensure the effectiveness of the treatment.